Trump's New Drug Tariffs: A Major Shift

0:00President Trump just dropped a major move, slapping a 100 percent tariff on patented drugs made outside the United States. This hits imports hard, but companies can drop it to 20 percent by shifting production stateside or even zero through special deals. The order side steps last February Supreme Court ruling that killed his bigger tariff plans using a national security loophole in trade law to keep pushing his America first agenda. Australian firm CSL out of Melbourne stands to feel the heat since they make a big chunk of those exports, but they've already poured cash into US factories to dodge the blow from these long-threatened tariffs. Officials say the goal is locking down drug supplies for emergencies like pandemics, arguing the US invents these meds but lets others produce them, leaving America vulnerable. Trump's team has cut deals with countries like Japan and the UK for lower rates around 10 to 15 percent, pulling hundreds of billions in, manufacturing back home, expect more shifts as this ramps up.

1:03Stay in form with Sydney News Today, AI-powered updates.